SALA, GESSICA
 Distribuzione geografica
Continente #
NA - Nord America 10.834
AS - Asia 5.965
EU - Europa 5.475
SA - Sud America 873
AF - Africa 151
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 10
Totale 23.320
Nazione #
US - Stati Uniti d'America 10.422
SG - Singapore 1.982
CN - Cina 1.374
IT - Italia 1.284
VN - Vietnam 905
DE - Germania 820
RU - Federazione Russa 712
BR - Brasile 665
HK - Hong Kong 658
SE - Svezia 612
IE - Irlanda 399
GB - Regno Unito 362
UA - Ucraina 317
CA - Canada 313
IN - India 254
FR - Francia 214
FI - Finlandia 176
AT - Austria 146
KR - Corea 110
BD - Bangladesh 91
PL - Polonia 89
TR - Turchia 83
NL - Olanda 77
AR - Argentina 74
IQ - Iraq 71
ES - Italia 69
ID - Indonesia 68
MX - Messico 63
JP - Giappone 61
PK - Pakistan 57
DK - Danimarca 49
PH - Filippine 45
BE - Belgio 42
ZA - Sudafrica 40
IR - Iran 39
EC - Ecuador 29
CO - Colombia 28
EG - Egitto 25
SA - Arabia Saudita 25
VE - Venezuela 24
CH - Svizzera 21
UZ - Uzbekistan 21
KE - Kenya 19
ET - Etiopia 16
PY - Paraguay 16
MA - Marocco 15
MY - Malesia 15
LT - Lituania 14
CL - Cile 13
AE - Emirati Arabi Uniti 11
CZ - Repubblica Ceca 11
JM - Giamaica 11
JO - Giordania 11
EU - Europa 9
PE - Perù 9
PT - Portogallo 9
TW - Taiwan 9
DZ - Algeria 8
IL - Israele 8
NP - Nepal 8
AU - Australia 7
GR - Grecia 7
OM - Oman 7
SY - Repubblica araba siriana 7
TN - Tunisia 7
UY - Uruguay 7
KZ - Kazakistan 6
RO - Romania 6
BO - Bolivia 5
HU - Ungheria 5
LB - Libano 5
LV - Lettonia 5
SK - Slovacchia (Repubblica Slovacca) 5
TH - Thailandia 5
AZ - Azerbaigian 4
BG - Bulgaria 4
CI - Costa d'Avorio 4
CR - Costa Rica 4
DO - Repubblica Dominicana 4
KG - Kirghizistan 4
LY - Libia 4
PS - Palestinian Territory 4
AL - Albania 3
CY - Cipro 3
MU - Mauritius 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
PA - Panama 3
RS - Serbia 3
TT - Trinidad e Tobago 3
BH - Bahrain 2
BZ - Belize 2
EE - Estonia 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
ML - Mali 2
Totale 23.288
Città #
Ann Arbor 1.609
Singapore 1.177
Ashburn 1.041
Woodbridge 679
San Jose 665
Hong Kong 628
Chandler 545
Frankfurt am Main 520
Houston 502
Milan 409
Fairfield 392
Dublin 383
Jacksonville 347
Wilmington 322
New York 295
Ho Chi Minh City 276
Dearborn 263
Santa Clara 257
Dallas 254
Hanoi 202
Los Angeles 202
Beijing 187
Seattle 173
Toronto 171
Princeton 152
Cambridge 137
Chicago 134
Vienna 129
The Dalles 116
Shanghai 111
Hefei 107
Nanjing 96
Seoul 87
Lauterbourg 78
Boardman 70
São Paulo 70
Buffalo 69
Helsinki 69
Council Bluffs 61
Lachine 61
Moscow 57
Munich 54
Altamura 53
Guangzhou 52
Da Nang 50
Rome 48
Jakarta 47
Lawrence 47
London 45
Orem 45
Kraków 44
Brussels 41
Chennai 38
Fremont 36
Tokyo 36
Haiphong 35
Changsha 33
Shenyang 33
Pisa 32
Nanchang 28
San Diego 28
Turku 28
Warsaw 28
Jinan 27
Tianjin 27
Dong Ket 26
Montreal 26
Turin 25
Andover 24
Baghdad 24
Phoenix 24
Pune 24
Rio de Janeiro 24
San Francisco 24
Denver 23
Zhengzhou 23
Amsterdam 22
Atlanta 22
Biên Hòa 22
Falls Church 22
Hebei 22
Grafing 21
Lahore 21
Monza 21
Ottawa 21
New Delhi 20
Piscataway 20
Poplar 20
Zurich 20
Belo Horizonte 19
Brooklyn 19
Jiaxing 19
Johannesburg 19
Lecco 19
Manchester 19
North Bergen 18
Secaucus 18
Stockholm 18
Tashkent 18
Hải Dương 17
Totale 14.782
Nome #
ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability 632
NMR-driven identification of anti-amyloidogenic compounds in green and roasted coffee extracts 520
Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease 484
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 441
Oxidative stress and altered mitochondrial dynamics in neurodegenerative processes 427
Ischemic Conditions Affect Rerouting of Tau Protein Levels: Evidences for Alteration in Tau Processing and Secretion in Hippocampal Neurons 400
NMR-based Lavado cocoa chemical characterization and comparison with fermented cocoa varieties: Insights on cocoa's anti-amyloidogenic activity 387
A panel of macroautophagy markers in lymphomonocytes of patients with amyotrophic lateral sclerosis 364
Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores (Nature Communications, (2021), 12, 1, (3417), 10.1038/s41467-021-22491-8) 362
Digested Cinnamon (Cinnamomum verum J. Presl) Bark Extract Modulates Claudin-2 Gene Expression and Protein Levels under TNFα/IL-1β Inflammatory Stimulus 357
Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients 354
HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation 354
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 350
Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition 350
Peripheral cytokine release in Alzheimer patients: Correlation with disease severity 345
MEF2D and MEF2C pathways disruption in sporadic and familial ALS patients 344
Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease 343
Reduced platelet glutamate uptake in Parkinson's disease 323
Study of alpha-synuclein and its catabolic pathways in ex vivo cells of patients with Parkinson’s disease 323
NMR-driven identification of cinnamon bud and bark components with anti-Aβ activity 323
In vitro study of autophagy dysfunctions associated with Parkinson’s disease 319
Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson's disease 315
TSPO Modulates Oligomeric Amyloid-β-Induced Monocyte Chemotaxis: Relevance for Neuroinflammation in Alzheimer's Disease 311
Rotenone down-regulates hspa8/hsc70 protein in vitro: a new possible toxic mechanism contributing to Parkinson’s disease 311
Riluzole display glutamate-independent antioxidant properties: relevance for ALS 308
Rotenone-induced down-regulation of HSPA8/hsc70 protein increases alphasynuclein in vitro: possible implications for Parkinson’s disease 308
New insights into the genetic etiology of Alzheimer's disease and related dementias 305
Alzheimer's Disease Prevention through Natural Compounds: Cell-Free, In Vitro, and In Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity 298
Effect of mitochondrial complex I inhibition on chaperone-mediated and myocyte enhancer factor 2D in human neuroblastoma cells 296
A Preliminary Study of Chaperone-Mediated Autophagy in ALS Lymphomonocytes 294
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores 293
Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines 292
Study Of Chaperone Mediated Autophagy in Lymphomonocytes of sporadic and familial als patients evidenced Hsc70 reduction and TDP-43 aggregation 289
Study of alpha-synuclein and its catabolic pathways in lymphomonocytes of patients with Parkinson's disease 288
Pravastatin acute neuroprotective effects depend on blood brain barrier integrity in experimental cerebral ischemia 281
Decreased platelet glutamate uptake and genetic risk factors in patients with Parkinson's disease 279
Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis 278
Nerve growth factor and transforming growth factor-β serum levels in acute stroke patients: Possible involvement of neurotrophins in cerebrovascular disease 278
Reduced expression of hsc70 protein in lymphomonocytes of patients with Parkinson's disease 278
Ischemic injury elicits the unconventional secretion of protein hallmarks of Alzheimer's disease onset as seeds for interneuronal propagation 276
Role of chaperone-mediated autophagy dysfunctions in the pathogenesis of Parkinson’s disease 273
Valproate and HDAC inhibition: A new epigenetic strategy to mitigate phenotypic severity in ALS? 271
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 270
Alpha-Synuclein, Oxidative Stress and Autophagy Failure: Dangerous Liaisons in Dopaminergic Neurodegeneration 269
Exploring the role of autophagy in the pathogenesis of rotenone-induced toxicity 269
Multi-pathway blood biomarkers to target and monitor multidimensional prevention of cognitive and functional decline (nested in the IN-TeMPO study framed within the world-wide FINGERS network) 268
Mef2d-mef2c pathways are altered in lymphomonocytes of patients with sporadic and familial form of amyotrophic lateral sclerosis 265
Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine 264
Platelet glutamate uptake as peripheral marker of excitotoxicity in neurodegenerative disorders 259
Assessment of chaperone-mediated autophagy in circulating lymphomonocytes of patients with Parkinson disease 258
Acute lipophilicity-dependent effect of intravascular simvastatin in the early phase of focal cerebral ischemia 255
MEF2D and MEF2C Pathways Disruption in Sporadic and Familial ALS Patients 253
Lack of evidence for oxidative stress in sporadic amyotrophic lateral sclerosis fibroblasts 252
Core blood biomarkers of Alzheimer's disease: A single-center real-world performance study 250
Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro 249
AUTOPHAGY ALTERATION UNDER ISCHEMIC CONDITION: A POSSIBLE LINK TO ALZHEIMER'S DISEASE 248
Huntington's disease and HDACi: Would sulpiride and valproate be of therapeutic value? 246
the MonzALS collaborative network 245
Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson's disease 244
MEF2C and MEF2D alterations in sporadic and familial ALS patients: a possible correlation with disease progression? 244
Myocyte Enhacer Factor 2 Pathway Disruption in Lymphomonocytes of Patients with Sporadic and Familial Form of Amyotrophic Lateral Sclerosis 241
Inhibition of retrograde transport modulates misfolded protein accumulation and clearance in motoneuron diseases 234
HSPA8 knock-down induces the accumulation of neurodegenerative disorder-associated proteins 232
Myocyte enhancer factor-2D expression in ALS lymphomonocytes 227
Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation 225
Chaperone mediated autophagy in Parkinson's disease: Study in peripheral blood cells from patients and in a cellular model 217
Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis 215
Macroautophagy is not altered in ALS lymphomonocytes 214
Dysfunction of chaperone-mediated autophagy in lymphomonocytes from patients with Parkinson's disease and in a cellular model 212
Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON) 209
Analysis of glutamate transporters in peripheral cells: A tool to invistigate excitotoxicity in neurodegenerative disorders 204
Myocyte Enhacer Factor-2 Pathway Is Altered In Amyotrophic Lateral Sclerosis Peripheral Blood Mononuclear Cells 187
Assessing glutamatergic function and dysfunction in peripheral tissues 184
Interactions between excitotoxicity and oxidative stress in ALS: clues for pharmacotherapy 182
Antioxidants partially restore glutamate transport defect in leber hereditary optic neuropathy cybrids 180
Increased interleukin-6 release from peripheral blood cells of patients after brain trauma 179
Valproate Treatment in an ALS Patient Carrying a c.194G>A Spastin Mutation and SMN2 Homozygous Deletion 173
Whole-blood global DNA methylation and phenotypic variability in ALS 171
Recent advances in the therapy of amyotrophic lateral sclerosis: Focus on excitotoxicity 167
Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset 160
Author Correction: Direct current stimulation enhances neuronal alpha-synuclein degradation in vitro (Scientific Reports, (2021), 11, 1, (2197), 10.1038/s41598-021-81693-8) 160
ALS genocopy due to co-existence of spastin mutation and SMN2 deletion? A 12 months open label trial with valproic acid 156
Neuroprotection and Non-Invasive Brain Stimulation: Facts or Fiction? 145
Multicomponent interventions and technologies to reduce the burden of frailty, functional, and cognitive decline: insights from the Age-It Research Program 138
Platelets 132
Multicenter Translational Trial of Remote Ischemic Conditioning in Acute Ischemic Stroke (TRICS BASIC) 95
Iatrogenic Cerebral Amyloid Angiopathy-Related Inflammation: A Multicenter Case Series 81
Effects of multidomain interventions on health outcomes in older adults: A systematic review and meta-analysis 15
Totale 23.767
Categoria #
all - tutte 69.921
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 69.921


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021241 0 0 0 0 0 0 0 0 0 0 98 143
2021/20221.120 97 126 109 100 81 113 45 57 50 69 108 165
2022/20232.119 190 615 193 239 163 321 26 117 144 17 50 44
2023/20241.674 81 79 104 88 201 456 239 90 79 14 31 212
2024/20253.377 170 407 276 135 253 185 161 139 318 549 278 506
2025/20268.777 1.107 571 689 934 1.000 463 1.474 403 908 893 335 0
Totale 23.767